Related Experiment Videos
Heart failure, renal function, and angiotensin converting enzyme inhibitors
Kidney International. Supplement
|May 1, 1987
Summary
Angiotensin-converting enzyme (ACE) inhibitors may initially lower glomerular filtration rate (GFR) in nonazotemic patients. Renal blood flow and GFR may recover over weeks as the body adapts to ACE inhibitor therapy.
Area of Science:
- Nephrology
- Pharmacology
- Cardiovascular Medicine
Background:
- Angiotensin-converting enzyme (ACE) inhibitors are widely prescribed for cardiovascular conditions.
- Their effects on renal function, particularly in nonazotemic patients, require detailed understanding.
- Autoregulation of renal blood flow and glomerular filtration rate (GFR) are critical for maintaining kidney function.
Purpose of the Study:
- To investigate the immediate and short-term effects of ACE inhibitors on GFR and renal blood flow in nonazotemic individuals.
- To examine the role of autoregulation mechanisms during ACE inhibitor therapy.
- To describe the subsequent changes in fluid balance, body weight, and blood pressure.
Main Methods:
- Observational study involving nonazotemic patients initiating ACE inhibitor therapy.
- Monitoring of GFR, renal blood flow, blood pressure, and body weight.
- Assessment of fluid and electrolyte balance, including serum sodium levels.
Main Results:
- Initial administration of ACE inhibitors may lead to a transient depression of GFR, potentially linked to a significant drop in blood pressure and reduced renal blood flow.
- Autoregulation of renal blood flow appears preserved, while GFR autoregulation is impaired during ACE inhibition.
- Sodium and water retention, plasma volume expansion, and temporary restoration of renal blood flow and GFR are observed.
- Natriuresis commences after 1-2 weeks, with gradual restoration of sodium balance and body weight over 4-8 weeks.
- As plasma volume decreases, blood pressure drops further, and GFR declines, with renal blood flow maintained by reduced renovascular resistance.
Conclusions:
- ACE inhibitors can transiently impair GFR in nonazotemic patients, primarily due to hemodynamic changes.
- The kidney exhibits adaptive responses including fluid retention followed by natriuresis.
- Understanding these dynamic changes is crucial for managing patients on ACE inhibitors and preserving renal function.